COMBINATION THERAPY FOR HEMATOLOGICAL MALIGNANCIES
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Aug 20, 2015
app pub date -
Feb 17, 2015
filing date -
Feb 18, 2014
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
Methods of treating, preventing or managing T-cell lymphomas are disclosed. The methods encompass administration of an HDAC inhibitor romidepsin and an alkylating agent bendamustine, also known as TREANDA®. Pharmaceutical compositions and single unit dosage forms suitable for use in the methods provided herein are also disclosed
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully